OPR - Delayed Quote • USD CBAY Jan 2025 8.000 put (CBAY250117P00008000) Follow 0.0500 0.0000 (0.00%) At close: February 12 at 9:31 AM EST Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw Table View List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Date Close Open High Low Volume O H L C Vol AAPL Loading Chart for CBAY250117P00008000 1D 5D 1M 3M 6M YTD 1Y 2Y 5Y All Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Recent News: CBAY Gilead Sciences Announces Completion of Acquisition of CymaBay Investing in CymaBay Therapeutics (NASDAQ:CBAY) three years ago would have delivered you a 540% gain CymaBay Announces European Medicines Agency Accepts for Review the Marketing Authorization Application for Seladelpar for the Treatment of Primary Biliary Cholangitis CymaBay Therapeutics Inc. (CBAY) Reports Q4 Loss, Misses Revenue Estimates CymaBay Reports Fourth Quarter and Year Ended December 31, 2023 Financial Results and Provides Corporate Update The New England Journal of Medicine Publishes Positive Phase 3 RESPONSE Data of CymaBay's Seladelpar in Primary Biliary Cholangitis CymaBay Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Biotech Stock Roundup: BIIB's Q4 Results, CBAY Up on GILD's Acquisition & Other Updates Director Janet Dorling Sells 6,000 Shares of CymaBay Therapeutics Inc (CBAY) Gilead (GILD) to Buy CBAY for $4.3B, Add PBC Drug to Pipeline CymaBay Rockets After Gilead Snaps Up The Liver-Focused Biotech For $4.3 Billion Stocks to Watch Monday: Diamondback, CymaBay, Gilead, Tod's
